ALC Stock Overview
Researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ALC from our risk checks.
Alcon Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 75.60 |
| 52 Week High | CHF 85.34 |
| 52 Week Low | CHF 62.24 |
| Beta | 0.73 |
| 11 Month Change | -8.23% |
| 3 Month Change | -6.41% |
| 1 Year Change | 18.91% |
| 33 Year Change | 1.59% |
| 5 Year Change | 35.65% |
| Change since IPO | 30.23% |
Recent News & Updates
Subdued Growth No Barrier To Alcon Inc.'s (VTX:ALC) Price
Nov 11
Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger
Oct 28Do Alcon's (VTX:ALC) Earnings Warrant Your Attention?
Oct 15Recent updates
Subdued Growth No Barrier To Alcon Inc.'s (VTX:ALC) Price
Nov 11Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger
Oct 28Do Alcon's (VTX:ALC) Earnings Warrant Your Attention?
Oct 15Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet
Sep 04Investor Optimism Abounds Alcon Inc. (VTX:ALC) But Growth Is Lacking
Jul 27A Look At The Fair Value Of Alcon Inc. (VTX:ALC)
Jul 13Should You Be Adding Alcon (VTX:ALC) To Your Watchlist Today?
Jun 24Alcon's (VTX:ALC) Returns On Capital Are Heading Higher
Jun 10These 4 Measures Indicate That Alcon (VTX:ALC) Is Using Debt Reasonably Well
May 28Alcon Inc.'s (VTX:ALC) Shareholders Might Be Looking For Exit
Apr 03Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors
Mar 21Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 01Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet
Feb 15Alcon Inc.'s (VTX:ALC) Business Is Yet to Catch Up With Its Share Price
Dec 22Returns On Capital Are Showing Encouraging Signs At Alcon (VTX:ALC)
Dec 04Calculating The Fair Value Of Alcon Inc. (VTX:ALC)
Nov 08Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet
Oct 18Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger
Aug 25A Look At The Fair Value Of Alcon Inc. (VTX:ALC)
Aug 10Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet
Jul 05Investors Will Want Alcon's (VTX:ALC) Growth In ROCE To Persist
May 12Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?
Apr 03Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors
Feb 03Returns Are Gaining Momentum At Alcon (VTX:ALC)
Jan 19Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet
Dec 18Do Alcon's (VTX:ALC) Earnings Warrant Your Attention?
Nov 02Alcon's (VTX:ALC) Returns On Capital Are Heading Higher
Sep 30We Think Alcon (VTX:ALC) Can Stay On Top Of Its Debt
Sep 11With Alcon Inc. (VTX:ALC) It Looks Like You'll Get What You Pay For
Aug 26These 4 Measures Indicate That Alcon (VTX:ALC) Is Using Debt Reasonably Well
Jun 10Alcon (VTX:ALC) Is Experiencing Growth In Returns On Capital
May 20There's Been No Shortage Of Growth Recently For Alcon's (VTX:ALC) Returns On Capital
Feb 13Shareholder Returns
| ALC | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | -2.0% | -3.3% | -1.4% |
| 1Y | 18.9% | 10.0% | 5.2% |
Return vs Industry: ALC exceeded the Swiss Medical Equipment industry which returned 13.8% over the past year.
Return vs Market: ALC exceeded the Swiss Market which returned 6.2% over the past year.
Price Volatility
| ALC volatility | |
|---|---|
| ALC Average Weekly Movement | 2.8% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in CH Market | 6.6% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: ALC has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: ALC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 25,000 | David Endicott | www.alcon.com |
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company’s Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery.
Alcon Inc. Fundamentals Summary
| ALC fundamental statistics | |
|---|---|
| Market cap | CHF 37.39b |
| Earnings (TTM) | CHF 1.02b |
| Revenue (TTM) | CHF 8.61b |
36.5x
P/E Ratio4.3x
P/S RatioIs ALC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALC income statement (TTM) | |
|---|---|
| Revenue | US$9.76b |
| Cost of Revenue | US$4.34b |
| Gross Profit | US$5.42b |
| Other Expenses | US$4.26b |
| Earnings | US$1.16b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.35 |
| Gross Margin | 55.50% |
| Net Profit Margin | 11.89% |
| Debt/Equity Ratio | 21.9% |
How did ALC perform over the long term?
See historical performance and comparison